Recent Development and Application of PEEK Material by Weike Technology

Mar.12
Recent Development and Application of PEEK Material by Weike Technology
Investors inquire about the application of PEEK material on machine skin by Weike Technology (301196.SZ) on interactive platform.

2Firsts, reporting from Shenzhen - Weike Technology (301196.SZ) recently responded to an investor inquiry regarding the application of its PEEK materials in artificial skin and the latest updates.

 

The company stated that it has established stable and mature production processes for PEEK material design, manufacturing, and processing. The material is primarily used in e-cigarettes, industrial printer heads, medical sterilization diagnostic equipment, and lead screws, with mass production already underway. 

 

The company has not provided the latest updates on its developments.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

PMI Japan Unveils Limited-Edition IQOS ILUMA i “Galaxy Blue,” Priced Around $47
PMI Japan Unveils Limited-Edition IQOS ILUMA i “Galaxy Blue,” Priced Around $47
Philip Morris Japan announced it will release the limited-edition IQOS ILUMA i “Galaxy Blue” across IQOS stores nationwide starting October 29, priced at JPY 6,980 including tax (about USD 47). The new model features a space-themed design, with a members-only promotion to run at the Nagoya IQOS store.
Oct.29 by 2FIRSTS.ai
JT Launches Ploom CUBE Heated Tobacco Device Featuring SMART HEATFLOW
JT Launches Ploom CUBE Heated Tobacco Device Featuring SMART HEATFLOW
Japan Tobacco has launched the Ploom CUBE heated-tobacco device in Japan, with a starter kit retail price of JPY 1,980 (approximately US$13). The cube-shaped device employs the same SMART HEATFLOW heating technology as Ploom AURA and delivers roughly 19–27 sticks per charge.
Oct.09 by 2FIRSTS.ai
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.
Oct.20 by 2FIRSTS.ai
Altria’s Nicotine Pouch Rollout in the U.S.: On! PLUS May Launch on October 14, Not Yet FDA-Approved
Altria’s Nicotine Pouch Rollout in the U.S.: On! PLUS May Launch on October 14, Not Yet FDA-Approved
Altria’s new nicotine pouch On! PLUS™ is slated to launch in the U.S. on October 14, debuting in North Carolina, Texas, and Florida. The product uses NICOSILK™ technology and will offer multiple nicotine strengths. FDA approval has not yet been granted, but Helix says it is proceeding in line with compliance requirements.
Oct.11 by 2FIRSTS.ai
ITGA 与 2Firsts 签署战略合作备忘录,共同支持全球烟草种植者
ITGA 与 2Firsts 签署战略合作备忘录,共同支持全球烟草种植者
ITGA Annual General Meeting 2025 held in Germany alongside InterTabac/InterSupply 2025 showcases global tobacco supply chain opportunities.
Sep.23 by 2FIRSTS.ai
British American Tobacco to Open glo™ Ginza Flagship Store in Tokyo on October 18
British American Tobacco to Open glo™ Ginza Flagship Store in Tokyo on October 18
BAT Japan to open two-storey glo™ Ginza flagship on Oct 18, 2025; sales + members’ lounge, promos; near IQOS.
Oct.11 by 2FIRSTS.ai